Clinical trial
Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to…
NCT00317486 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00317486 |
|---|---|
| Title | Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology |
| Official title | A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Tracleer (Bosentan) on Oxygen Saturation and Cardiac Hemodynamics in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Arterial Hypertension Related to Eisenmenger Physiology |
| Intervention type | Drug |
| Interventions | bosentan |
| Enrollment | 54 |
| Start date | Sep 1, 2003 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Apr 25, 2006 |
| Last update posted | Feb 4, 2025 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: